Skip to main content

Change location

You are currently on the South Korea (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
    • South Korea (한국어)
  • Home
  • we are bracco
    We are Bracco

    Welcome to a World of contrasts

    • Our businesses
    • Purpose and values
    • Our history
    • 재단
    • Responsibility and Ethical conduct
  • Our Portfolio

    Proven offerings for a proven difference

    • X-ray/CT
      • Contrast agents

        • Iopamiro 300
        • Iopamiro 370
        • Iomeron 300
        • Iomeron 350
        • Iomeron 400
      • Medical devices

        • CT Exprès
        • Empower CTA +
    • MRI
      • Contrast agents

        • MultiHance Pre-filled Syringe
        • ProHance Injection
        • ProHance Pre-filled Syringe
      • Medical Devices

        • Empower MR
    • Ultrasound
      • Contrast agents

        • SonoVue
      • Software

        • VueBox
    • Digital solutions
    • Oncology
    • Cardiology
  • Woman looking into microscope
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
  • knowledge
    Knowledge

    Current activities and future opportunities

    • E-learning
    • Partnerships in education
    • Event calendar
  • Ceriano Laghetto
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Page
Privacy Policy Privacy Policy
Bracco logo
Page
Terms of use Terms of Use
Bracco logo
Page
Imprint Disclaimer for the Bracco Website
Bracco logo
Page
X-Ray/CT Since its inception, Computed Tomography (CT) has revolutionized medical imaging. By creating detailed images of any part of the body, including internal organs, bones, soft tissue, and blood vessels, CT scans can be used to diagnose disease or injury as well as to plan medical, surgical, or interventional treatments.
A patient is about to be put through a computed tomography machine.
Page
MRI Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic technique using a strong static magnetic field and radio waves to create images of the body. MRI provides a high level of soft tissue contrast combined with high spatial and temporal resolution.
A patient is getting a magnetic resonance imaging scan.
Page
Ultrasound Ultrasound is the most widely used and a cost-effective imaging technology. The combination of ultrasound contrast agents with the latest evolving equipment has the potential to transform the clinical role of ultrasound to provide a flexible, cost-effective imaging capability equivalent to existing established modalities such as MRI, CT, and X-ray.
CEUS2
Page
Digital solutions Digital health, or digital healthcare, is a broad, multidisciplinary concept that includes concepts from the intersection between technology and healthcare. Digital health applies digital transformation to the healthcare field, incorporating software, hardware and services under its umbrella.
A radiologist analysing results from a brain scan.
Page
Cardiology Despite the availability of effective therapies, ischaemic heart disease remains the leading cause of death around the world. Early and proper diagnosis is key to reducing cardiovascular mortality and diagnostic imaging plays a crucial role here.
A surgeon preparing for surgery.
Page
Oncology According to the World Health Organization (WHO), in 2020 cancer accounted for nearly 10 million deaths worldwide – that’s almost one in every six deaths – with cancers of the lung, colon, and rectum, and prostate being the most common.
Laboratory researcher is looking through a microscope.
Product
CT Exprès A unique 3-channel syringeless contrast media CT scanner injector.
Bracco logo
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182